ENSG · Ensign Group, Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.38B | - | $1.30B | $1.22B | $1.17B | - | $1.08B | $1.04B | $1.01B | - |
| Cost of Revenue | $1.10B | - | $1.04B | $971.78M | $927.85M | - | $859.99M | $820.36M | $799.26M | - |
| Gross Profit | $286.48M | - | $251.75M | $249.63M | $245.19M | - | $221.78M | $215.93M | $210.91M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $74.21M | - | $67.37M | $69.11M | $62.55M | - | $56.18M | $56.19M | $57.16M | - |
| Total Operating Expenses | $1.26B | - | $1.20B | $1.12B | $1.07B | - | $992.44M | $950.31M | $927.95M | - |
| D&A | $28.80M | - | $26.63M | $25.79M | $24.19M | - | $21.47M | $20.49M | $19.66M | - |
| Operating Income | $124.85M | - | $96.22M | $103.90M | $101.37M | - | $89.34M | $85.97M | $82.22M | - |
| Interest Expense | $1.93M | - | $1.97M | $2.02M | $1.96M | - | $2.02M | $2.04M | $1.96M | - |
| Income Tax | $28.82M | - | $22.69M | $27.89M | $26.23M | - | $20.11M | $20.88M | $20.64M | - |
| Net Income | $99.67M | - | $83.84M | $84.40M | $80.28M | - | $78.44M | $71.01M | $68.83M | - |
| EPS - Basic | $1.73 | - | $1.46 | $1.48 | $1.41 | - | $1.38 | $1.26 | $1.22 | - |
| EPS - Diluted | $1.67 | - | $1.42 | $1.44 | $1.37 | - | $1.34 | $1.22 | $1.19 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $539.50M | $503.88M | $443.67M | $363.97M | $282.67M | $464.60M | $532.07M | $477.34M | $511.84M | $509.63M |
| Accounts Receivable | $663.25M | $636.99M | $612.74M | $578.05M | $584.05M | $569.90M | $554.09M | $547.12M | $519.44M | $485.04M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $116.13M | $97.33M | $105.80M | $102.80M | $95.33M | $98.95M | $90.27M | $88.65M | $82.64M | $92.81M |
| Current Assets | $1.32B | $1.27B | $1.21B | $1.07B | $986.39M | $1.16B | $1.20B | $1.12B | $1.09B | $1.05B |
| Total Assets | $5.61B | $5.46B | $5.23B | $4.93B | $4.76B | $4.67B | $4.63B | $4.44B | $4.31B | $4.18B |
| Current Liabilities | $848.05M | $894.35M | $825.23M | $755.54M | $705.21M | $743.43M | $768.94M | $730.77M | $709.72M | $734.75M |
| Long-term Debt | $136.49M | $137.53M | $138.56M | $139.58M | $140.59M | $141.59M | $142.58M | $143.56M | $144.53M | $145.50M |
| Total Liabilities | $3.24B | $3.23B | $3.10B | $2.91B | $2.83B | $2.83B | $2.88B | $2.77B | $2.72B | $2.68B |
| Stockholders' Equity | $2.37B | $2.23B | $2.12B | $2.02B | $1.93B | $1.84B | $1.75B | $1.66B | $1.58B | $1.49B |
| Retained Earnings | $1.85B | $1.76B | $1.66B | $1.58B | $1.50B | $1.43B | $1.35B | $1.28B | $1.21B | $1.14B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $100.15M | - | - | - | $72.22M | - | - | - | $35.31M | - |
| Investing Cash Flow | ($71.19M) | - | - | - | ($243.80M) | - | - | - | ($34.66M) | - |
| Financing Cash Flow | $6.65M | - | - | - | ($10.35M) | - | - | - | $1.56M | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 20.7% | - | 19.4% | 20.4% | 20.9% | - | 20.5% | 20.8% | 20.9% | - |
| Operating margin | 9.0% | - | 7.4% | 8.5% | 8.6% | - | 8.3% | 8.3% | 8.1% | - |
| EBITDA margin | 11.1% | - | 9.5% | 10.6% | 10.7% | - | 10.2% | 10.3% | 10.1% | - |
| Net margin | 7.2% | - | 6.5% | 6.9% | 6.8% | - | 7.3% | 6.9% | 6.8% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 5.4% | - | 5.2% | 5.7% | 5.3% | - | 5.2% | 5.4% | 5.7% | - |
| Effective tax rate | 22.4% | - | 21.3% | 24.8% | 24.6% | - | 20.4% | 22.7% | 23.1% | - |
| Return on assets | 1.8% | - | 1.6% | 1.7% | 1.7% | - | 1.7% | 1.6% | 1.6% | - |
| Return on equity | 4.2% | - | 4.0% | 4.2% | 4.2% | - | 4.5% | 4.3% | 4.4% | - |
| Return on invested capital | 3.9% | - | 3.4% | 3.6% | 3.7% | - | 3.8% | 3.7% | 3.7% | - |
| Liquidity | ||||||||||
| Current ratio | 1.56 | 1.42 | 1.46 | 1.41 | 1.40 | 1.56 | 1.56 | 1.53 | 1.53 | 1.42 |
| Quick ratio | 1.56 | 1.42 | 1.46 | 1.41 | 1.40 | 1.56 | 1.56 | 1.53 | 1.53 | 1.42 |
| Cash ratio | 0.64 | 0.56 | 0.54 | 0.48 | 0.40 | 0.62 | 0.69 | 0.65 | 0.72 | 0.69 |
| Leverage | ||||||||||
| Debt / Equity | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | 0.08 | 0.08 | 0.09 | 0.09 | 0.10 |
| Debt / Assets | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Debt / EBITDA | 0.89 | - | 1.13 | 1.08 | 1.12 | - | 1.29 | 1.35 | 1.42 | - |
| Interest coverage | 64.6x | - | 48.8x | 51.3x | 51.6x | - | 44.1x | 42.1x | 41.9x | - |
| Equity multiplier | 2.37 | 2.45 | 2.47 | 2.44 | 2.47 | 2.54 | 2.65 | 2.68 | 2.73 | 2.80 |
| Liabilities / Assets | 0.58 | 0.59 | 0.59 | 0.59 | 0.59 | 0.61 | 0.62 | 0.63 | 0.63 | 0.64 |
| Efficiency | ||||||||||
| Asset turnover | 0.25 | - | 0.25 | 0.25 | 0.25 | - | 0.23 | 0.23 | 0.23 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 175d | - | 173d | 173d | 182d | - | 187d | 193d | 188d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | 39d | - | 37d | 39d | 37d | - | 38d | 39d | 38d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 120.7x | - | 121.7x | 107.1x | 94.5x | - | 107.3x | 101.4x | 104.6x | - |
| P / B | 5.1x | - | 4.8x | 4.5x | 3.9x | - | 4.8x | 4.3x | 4.6x | - |
| P / S | 8.7x | - | 7.9x | 7.4x | 6.5x | - | 7.8x | 6.9x | 7.1x | - |
| EV / EBITDA | 75.5x | - | 80.4x | 68.0x | 59.2x | - | 72.3x | 64.3x | 67.1x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 17.8% | - | 19.8% | 17.9% | 16.1% | - | 15.0% | 12.5% | 13.9% | - |
| Revenue CAGR (3y) | 15.9% | - | 19.0% | 18.6% | 18.0% | - | 17.4% | 17.5% | 17.2% | - |
| Revenue CAGR (5y) | 17.1% | - | 16.7% | 15.9% | 14.7% | - | 12.5% | 12.5% | 13.0% | - |
| Gross profit growth (YoY) | 16.8% | - | 13.5% | 15.6% | 16.3% | - | 11.0% | 8.7% | 10.7% | - |
| Operating income growth (YoY) | 23.2% | - | 7.7% | 20.9% | 23.3% | - | 12.0% | 10.4% | 9.8% | - |
| Net income growth (YoY) | 24.2% | - | 6.9% | 18.9% | 16.6% | - | 22.8% | 11.0% | 15.0% | - |
| EPS growth (YoY) | 21.9% | - | 6.0% | 18.0% | 15.1% | - | 20.7% | 8.9% | 13.3% | - |
| EPS CAGR (3y) | 16.7% | - | 12.8% | 12.6% | 15.5% | - | 17.3% | 11.9% | 11.4% | - |
| EPS CAGR (5y) | 14.2% | - | 13.0% | 14.6% | 13.4% | - | 22.8% | 19.1% | 19.4% | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 22.8% | 21.5% | 21.3% | 21.7% | 22.1% | 23.1% | 19.7% | 19.4% | 19.7% | 19.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$4.96B totalSkilled Services Segment$4.84B · 97.4%
Standard Bearer Segment$126.93M · 2.6%
Peer comparison
Same SIC group: Services-Skilled Nursing Care Facilities
Comparing ENSIGN GROUP against the 3 most active filers in the same SIC group.
Dividends
$0.26/share trailing 12 months · +4.1% YoY
| Ex-date | Per share |
|---|---|
| Mar 31, 2026 | $0.0650 |
| Dec 31, 2025 | $0.0650 |
| Sep 30, 2025 | $0.0630 |
| Jun 30, 2025 | $0.0630 |
| Mar 31, 2025 | $0.0630 |
| Dec 31, 2024 | $0.0630 |
| Sep 30, 2024 | $0.0600 |
| Jun 28, 2024 | $0.0600 |
| Mar 27, 2024 | $0.0600 |
| Dec 28, 2023 | $0.0600 |
| Sep 28, 2023 | $0.0580 |
| Jun 29, 2023 | $0.0580 |
| Mar 30, 2023 | $0.0580 |
| Dec 29, 2022 | $0.0580 |
| Sep 29, 2022 | $0.0550 |
| Jun 29, 2022 | $0.0550 |
| Mar 30, 2022 | $0.0550 |
| Dec 30, 2021 | $0.0550 |
| Sep 29, 2021 | $0.0530 |
| Jun 29, 2021 | $0.0530 |
| Mar 30, 2021 | $0.0530 |
| Dec 30, 2020 | $0.0530 |
| Sep 29, 2020 | $0.0500 |
| Jun 29, 2020 | $0.0500 |